Journal
EUROPEAN JOURNAL OF HUMAN GENETICS
Volume 17, Issue 2, Pages 151-158Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ejhg.2008.154
Keywords
RECQL4; RAPADILINO syndrome; Rothmund-Thomson syndrome; Baller-Gerold syndrome; osteosarcoma; lymphoma
Funding
- Helsinki Graduate School in Biotechnology and Molecular Biology
- Finnish Cancer Organizations
- National Institutes of Health [HD024064]
- NICHD [K08HD42136]
- Doris Duke Charitable Foundation
Ask authors/readers for more resources
Mutations in the RECQL4 gene can lead to three clinical phenotypes with overlapping features. All these syndromes, Rothmund-Thomson (RTS), RAPADILINO and Baller-Gerold (BGS), are characterized by growth retardation and radial defects, but RAPADILINO syndrome lacks the main dermal manifestation, poikiloderma that is a hallmark feature in both RTS and BGS. It has been previously shown that RTS patients with RECQL4 mutations are at increased risk of osteosarcoma, but the precise incidence of cancer in RAPADILINO and BGS has not been determined. Here, we report that RAPADILINO patients identified as carriers of the c.1390+2delT mutation (p.Ala420_Ala463del) are at increased risk to develop lymphoma or osteosarcoma (6 out of 15 patients). We also summarize all the published RECQL4 mutations and their associated cancer cases and provide an update of 14 novel RECQL4 mutations with accompanying clinical data.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available